During the past decade, Benefis Healthcare- Sletten Cancer Institute conducted 191 clinical trials. In the 10-year time frame, 191 clinical trials started and 219 clinical trials were completed, i.e. on average, 114.7% percent of trials that started reached the finish line to date. In the past 5 years, 51 clinical trials started and 83 clinical trials were completed. i.e. 162.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Benefis Healthcare- Sletten Cancer Institute" #1 sponsor was "National Cancer Institute (NCI)" with 174 trials, followed by "SWOG Cancer Research Network" with 114 trials sponsored, "Alliance for Clinical Trials in Oncology" with 100 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 26 trials sponsored and "NRG Oncology" with 26 trials sponsored. Other sponsors include 55 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Benefis Healthcare- Sletten Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 309 trials as a collaborator, "NRG Oncology" with 43 trials as a collaborator, "Cancer and Leukemia Group B" with 17 trials as a collaborator, "NCIC Clinical Trials Group" with 17 trials as a collaborator and "SWOG Cancer Research Network" with 16 trials as a collaborator. Other collaborators include 100 different institutions and companies that were collaborators in the rest 58 trials.

According to Clinical.Site data, the most researched conditions in "Benefis Healthcare- Sletten Cancer Institute" are "Breast Cancer" (41 trials), "Lung Cancer" (27 trials), "Lymphoma" (18 trials), "Prostate Cancer" (17 trials) and "Leukemia" (13 trials). Many other conditions were trialed in "Benefis Healthcare- Sletten Cancer Institute" in a lesser frequency.

Most popular intervention types in "Benefis Healthcare- Sletten Cancer Institute" are "Drug" (397 trials), "Other" (249 trials), "Biological" (177 trials), "Radiation" (105 trials) and "Procedure" (104 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (110 trials), "Quality-of-Life Assessment" (86 trials), "Questionnaire Administration" (47 trials), "Paclitaxel" (46 trials) and "Carboplatin" (43 trials). Other intervention names were less common.

The vast majority of trials in "Benefis Healthcare- Sletten Cancer Institute" are 380 trials for "All" genders, 85 trials for "Female" genders and 32 trials for "Male" genders.

Currently, there are NaN active trials in "Benefis Healthcare- Sletten Cancer Institute". undefined are not yet recruiting, 86 are recruiting, 172 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 187 completed trials in Benefis Healthcare- Sletten Cancer Institute, 10 suspended trials, and 35 terminated clinical trials to date.

Out of the total trials that were conducted in Benefis Healthcare- Sletten Cancer Institute, 24 "Phase 1" clinical trials were conducted, 236 "Phase 2" clinical trials and 239 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 14 trials that are defined as “Not Applicable".